Table 3.
Comparisons of the clinical characteristics of participants with low PTH level who had undergone total PTX and paired participants with SHPT.
| PTX-low PTH group (n = 18) | Paired-SHPT group (n = 18) | p value | |
|---|---|---|---|
| Age (year) | 58.17 ± 7.73 | 57.89 ± 7.84 | 0.311 |
| Sex | 0.305 | ||
| Male | 13 (72.2) | 9 (50) | |
| Female | 5 (27.8) | 9 (50) | |
| Diabetes [n (%)] | 16 (88.9) | 15 (83.3) | 1.000 |
| Dialysis vintage (year) | 11.67 ± 5.18 | 10.17 ± 3.85 | 0.016 |
| Serum iPTH (pg/ml) | 15.21 | 1131.22 | |
| Serum Ca (mmol/l) | 2.21 ± 0.20 | 2.34 ± 0.21 | 0.072 |
| Serum P Grouping | 1.000 | ||
| ⩾1.78 mmol/l | 8 (44.4) | 9 (50) | |
| < 1.78 mmol/l | 10 (55.6) | 9 (50) | |
| HGB (g/l) | 108.3 ± 15.8 | 111.3 ± 11.4 | 0.123 |
| ALB (g/l) | 41.29 ± 3.76 | 39.14 ± 2.19 | 0.062 |
| Composite endpoint events [n (%)] | 9 (50) | 5 (27.8) | 0.305 |
| Survival time (month) | 17.83 ± 8.08 | 19.56 ± 7.44 | 0.534 |
ALB, serum albumin; Ca, calcium; HGB, hemoglobin; iPTH, intact parathyroid hormone; P, phosphorus; PTH, parathyroid hormone; PTX, parathyroidectomy; SPTH, secondary hyperparathyroidism.